阿司匹林对肝细胞癌的作用及其相关机制被引量：1

Effect of aspirin on hepatocellular carcinoma and its related mechanism

导出

摘要阿司匹林作为传统的非甾体类抗炎药,对于消化道肿瘤有治疗和预防作用,肝细胞癌作为消化道最常见的恶性肿瘤之一,寻找到有效的预防和治疗措施是十分必要的。现综述阿司匹林对肝细胞癌作用的研究进展及其机制,以期为今后的相关临床治疗提供参考。 Aspirin,as a traditional non-steroidal anti-inflammatory drug,has therapeutic and preventive effects on gastrointestinal tumors.Hepatocellular carcinoma is one of the most common malignant tumors in the digestive tract,so it is necessary to find effective preventive and therapeutic measures.This article reviews the research progress and mechanism of aspirin on hepatocellular carcinoma with a view to provide references for future clinical treatment.

作者刘宇维徐洪芹周强牛俊奇 Liu Yuwei;Xu Hongqin;Zhou Qiang;Niu Junqi(Department of Hepatology,The First Hospital of Jilin University,Changchun 130021,China)

机构地区吉林大学第一医院肝胆胰内科

出处《中华肝脏病杂志》 CAS CSCD 北大核心 2020年第9期799-802,共4页 Chinese Journal of Hepatology

基金国家重点基础研究发展计划(2015CB554304)。

关键词阿司匹林肝细胞癌机制 Aspirin Hepatocellular carcinoma Mechanism

分类号 R735.7 [医药卫生—肿瘤]

引文网络
相关文献

参考文献4

1程变巧,林伟国,朱琪,李瑶,林园香.阿司匹林调控Wnt/β-catenin信号通路抑制肝癌侵袭[J].临床医药文献电子杂志,2018,5(7):13-15. 被引量：5
2张伟,孙惠川,熊宇泉,庄鹏远,朱小东,汤钊猷.阿司匹林抑制核因子-κB增强索拉非尼对肝癌的促凋亡作用[J].中华实验外科杂志,2011,28(10):1620-1622. 被引量：7
3Yun-xia Liu,Jin-yan Feng,Ming-ming Sun,Bo-wen Liu,Guang Yang,Ya-nan Bu,Man Zhao,Tian-jiao Wang,Wei-ying Zhang,Hong-feng Yuan,Xiao-dong Zhang.Aspirin inhibits the proliferation of hepatoma cells through controlling GLUT 1-mediated glucose metabolism[J].Acta Pharmacologica Sinica,2019,40(1):122-132. 被引量：10
4Lu Lu,Ming Lu,Yuan Pei,Jinhong Chen,Lunxiu Gin,Wenwei Zhu,Huliang Jia.Down-regulation of SDFI-α expression in tumor microenvironment is associated with aspirin- mediated suppression of the pro-metastasis effect of sorafenib in hepatocellular carcinoma[J].Acta Biochimica et Biophysica Sinica,2015,47(12):988-996. 被引量：7

二级参考文献62

1彭勇,李敬东,彭祥玉,刘海忠,刘作金,龚建平.核因子-κB圈套对Kupper细胞活化的抑制作用及其机制[J].中华实验外科杂志,2006,23(7):815-817. 被引量：7
2Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med,2008,359:378-390.
3Hikita H, Takehara T, Shimizu S, et al. The bcl-xL inhibitor, ABT- 737 ,efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib. Hepatology, 2010, 52: 1310- 1321.
4Shimizu S, Takehara T, Hikita H, et al. The let-7 family of microRNAs inhibits bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol,2010 ,52 :698-704.
5Wu JM, Sheng H, Saxena R, et al. NF-kappaB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapy. Cancer Lett ,2009,278 : 145-155.
6Kopp E,Ghosh S. Inhibition of NF-KB by sodium salicylate and aspirin. Science, 1994,265:956-959.
7Din FV, Stark LA, Dunlop MG. Aspirin-induced nuclear translocation of NFkappaB and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiency. Br J Cancer,2005,92: 1137-1143.
8Simeonidis S, Stauber D, Chen G, et al. Mechanisms by which IkappaB proteins control NF-kappaB activity. Proc Natl Acad Sci USA, 1999,96:49-54.
9Alfonso LF, Srivenugopal KS, Arumugam TV, et al. Aspirin inhibits camptothecin-induced p21CIPl levels and potentiates apoptosis in human breast cancer cells. Int J Oncol,2009 ,34 :597-608.
10Tang ZY, Ye SL, Liu YK, Qin LX, Sun HC, Ye QH, Wang L, et al. A dec- ade's studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol 2004, 130: 187-196.